Your session is about to expire
← Back to Search
Behavioural Intervention
Virtual Mirror Therapy for Phantom Limb Pain
N/A
Waitlist Available
Led By Conley Carr, MD
Research Sponsored by University of Alabama at Birmingham
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Presence of unilateral upper extremity amputation with continued intermittent or persistent phantom limb pain symptoms > 1 yr after amputation
Pain must be >=4 of 10 on the VAS at least intermittently (i.e. can have no pain at times but they must at least have 4/10 intensity of pain when pain does occur)
Must not have
Active nausea/vomiting
Uncontrolled vertigo
Timeline
Screening 3 weeks
Treatment Varies
Follow Up week 6 - week 52
Awards & highlights
No Placebo-Only Group
Summary
This trial will investigate whether Virtual Mirror therapy can reduce chronic phantom limb pain for amputees. If successful, a larger trial will be conducted.
Who is the study for?
This trial is for individuals with one upper limb amputated who have experienced phantom limb pain of at least moderate intensity (4/10) intermittently or persistently for over a year. It's not suitable for those with uncontrolled mental health conditions, seizure disorders, severe simulator sickness, certain eye conditions, extreme claustrophobia, active nausea/vomiting, vertigo, facial wounds that could interfere with a headset use, or immunodeficiency.
What is being tested?
The study is testing Virtual Mirror Therapy to see if it can help reduce chronic phantom limb pain in people who've had an arm amputated. This pilot study will set the stage for a larger-scale randomized controlled trial including both arm and leg amputees.
What are the potential side effects?
Potential side effects may include discomfort from wearing the virtual reality headset like simulator sickness (similar to motion sickness), eye strain or headache. Since this therapy is non-invasive and does not involve drugs or surgery, serious side effects are unlikely.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowSelect...
I have had one arm amputated and still feel pain in the missing part for over a year.
Select...
My pain reaches a level of 4 out of 10 at times.
Exclusion Criteria
You may be eligible for the trial if you check “No” for criteria below:Select...
I am currently experiencing nausea or vomiting.
Select...
I suffer from severe dizziness that I cannot control.
Select...
I have had shingles in my eye.
Select...
I am blind in both eyes.
Select...
My bipolar disorder or schizophrenia is not under control.
Select...
I do not have an uncontrolled immune deficiency.
Select...
I have no facial wounds near my eyes, nose, or cheeks that could affect wearing a headset.
Select...
I have conjunctivitis.
Select...
I have seizures that are not controlled by medication.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ week 6 - week 52
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~week 6 - week 52
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Primary study objectives
Baseline Numeric Rating Scale of Chronic Phantom Limb Pain
Baseline Pain Disability Questionnaire of Chronic Phantom Limb Pain
Change from Baseline Numeric Rating Scale at Session 2
+7 moreSecondary study objectives
Change in Quality from Baseline Chronic Phantom Limb Pain at Session 2
Change in Quality from Baseline Chronic Phantom Limb Pain at Session 3
Change in Quality from Baseline Chronic Phantom Limb Pain at Session 4
+4 moreAwards & Highlights
No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.
Trial Design
1Treatment groups
Experimental Treatment
Group I: Unilateral upper extremity amputeesExperimental Treatment1 Intervention
Unilateral upper extremity amputees suffering from chronic phantom limb pain \> 1 yr will be recruited from a hospital based outpatient Physical Medicine and Rehabilitation Amputee Clinic at UAB.
Find a Location
Who is running the clinical trial?
University of Alabama at BirminghamLead Sponsor
1,646 Previous Clinical Trials
2,342,773 Total Patients Enrolled
Conley Carr, MDPrincipal InvestigatorThe University of Alabama at Birmingham
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- My bipolar disorder or schizophrenia is not under control.I have had shingles in my eye.I am blind in both eyes.I have had one arm amputated and still feel pain in the missing part for over a year.I suffer from severe dizziness that I cannot control.I do not have an uncontrolled immune deficiency.I have no facial wounds near my eyes, nose, or cheeks that could affect wearing a headset.I am currently experiencing nausea or vomiting.My pain reaches a level of 4 out of 10 at times.You have experienced serious motion sickness in the past.Currently experiencing severe mental illness.I have conjunctivitis.I have seizures that are not controlled by medication.You have extreme fear of enclosed spaces.
Research Study Groups:
This trial has the following groups:- Group 1: Unilateral upper extremity amputees
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Share this study with friends
Copy Link
Messenger